TheKir2.1inward-rectifier potassium channelis alipid-gated ion channelencoded by theKCNJ2gene.[5][6][7][8]

KCNJ2
Identifiers
AliasesKCNJ2,ATFB9, HHBIRK1, HHIRK1, IRK1, KIR2.1, LQT7, SQT3, potassium voltage-gated channel subfamily J member 2, potassium inwardly rectifying channel subfamily J member 2
External IDsOMIM:600681;MGI:104744;HomoloGene:20249;GeneCards:KCNJ2;OMA:KCNJ2 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000891

NM_008425

RefSeq (protein)

NP_000882

NP_032451

Location (UCSC)Chr 17: 70.17 – 70.18 MbChr 11: 110.96 – 110.97 Mb
PubMedsearch[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Clinical significance

edit

A defect in this gene is associated withAndersen-Tawil syndrome.[9]

A mutation in the KCNJ2 gene has also been shown to causeshort QT syndrome.[10]

In research

edit

In neurogenetics, Kir2.1 is used inDrosophilaresearch to inhibit neurons, as overexpression of this channel willhyperpolarizecells.

In optogenetics, a trafficking sequence from Kir2.1 has been added tohalorhodopsinto improve its membrane localization. The resulting protein eNpHR3.0 is used inoptogenetic researchto inhibit neurons with light.[11]

Expression of Kir2.1 gene in humanHEK293 cellsinduce a transient outward current, creating a steadymembrane potentialclose to thereversal potentialof potassium.[12]

Interactions

edit

Kir2.1 has been shown tointeractwith:

References

edit
  1. ^abcGRCh38: Ensembl release 89: ENSG00000123700Ensembl,May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000041695Ensembl,May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Hansen SB (May 2015)."Lipid agonism: The PIP2 paradigm of ligand-gated ion channels".Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.1851(5): 620–8.doi:10.1016/j.bbalip.2015.01.011.PMC4540326.PMID25633344.
  6. ^Raab-Graham KF, Radeke CM, Vandenberg CA (1994). "Molecular cloning and expression of a human heart inward rectifier potassium channel".NeuroReport.5(18): 2501–5.doi:10.1097/00001756-199412000-00024.PMID7696590.
  7. ^Derst C, Karschin C, Wischmeyer E, Hirsch JR, Preisig-Müller R, Rajan S, Engel H, Grzeschik K, Daut J, Karschin A (2001). "Genetic and functional linkage of Kir5.1 and Kir2.1 channel subunits".FEBS Lett.491(3): 305–11.Bibcode:2001FEBSL.491..305D.doi:10.1016/S0014-5793(01)02202-5.PMID11240146.S2CID14452157.
  8. ^Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S, Vandenberg CA (2005). "International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels".Pharmacol. Rev.57(4): 509–26.doi:10.1124/pr.57.4.11.PMID16382105.S2CID11588492.
  9. ^Donaldson MR, Yoon G, Fu YH, Ptacek LJ (2004). "Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity".Ann. Med.36(Suppl 1): 92–7.doi:10.1080/17431380410032490.PMID15176430.S2CID7362563.
  10. ^Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, Napolitano C, Anumonwo J, di Barletta MR, Gudapakkam S, Bosi G, Stramba-Badiale M, Jalife J (April 2005)."A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene".Circ. Res.96(7): 800–7.doi:10.1161/01.RES.0000162101.76263.8c.PMID15761194.
  11. ^Gradinaru V, Zhang F, Ramakrishnan C, Mattis J, Prakash R, Diester I, Goshen I, Thompson KR, Deisseroth K (April 2010)."Molecular and cellular approaches for diversifying and extending optogenetics".Cell.141(1): 154–65.doi:10.1016/j.cell.2010.02.037.PMC4160532.PMID20303157.
  12. ^Zhang DY, Lau CP, Li GR (2009-04-01). "Human Kir2.1 channel carries a transient outward potassium current with inward rectification".Pflügers Archiv: European Journal of Physiology.457(6): 1275–1285.doi:10.1007/s00424-008-0608-0.ISSN1432-2013.PMID19002489.S2CID3120804.
  13. ^Nehring RB, Wischmeyer E, Döring F, Veh RW, Sheng M, Karschin A (2000)."Neuronal inwardly rectifying K(+) channels differentially couple to PDZ proteins of the PSD-95/SAP90 family".J. Neurosci.20(1): 156–62.doi:10.1523/JNEUROSCI.20-01-00156.2000.PMC6774109.PMID10627592.
  14. ^Kurschner C, Yuzaki M (1999)."Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein".J. Neurosci.19(18): 7770–80.doi:10.1523/JNEUROSCI.19-18-07770.1999.PMC6782450.PMID10479680.
  15. ^Grishin A, Li H, Levitan ES, Zaks-Makhina E (2006)."Identification of gamma-aminobutyric acid receptor-interacting factor 1 (TRAK2) as a trafficking factor for the K+ channel Kir2.1".J. Biol. Chem.281(40): 30104–11.doi:10.1074/jbc.M602439200.PMID16895905.

Further reading

edit
edit